Published May 15, 2019
| Version v1
Journal article
Open
HPV Vaccines: Effectiveness and Adverse Effects
- 1. Department of Obstetrics & Gynecology of General Hospital in Trikala, Trikala, Greece 2Medical School and Department of Health Sciences, European University Cyprus, Cyprus
- 2. Medical School and Department of Health Sciences, European University Cyprus, Cyprus
- 3. Clinical Oncology Department, Norwich University Hospital, UK
- 4. Department of Hygiene Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Description
Preventive vaccination against human papillomavirus is the new practice in the treatment of cervical cancer. The successful vaccination programs include the use of three vaccines, capable of causing neutralization of antibodies from the virus particles, together with their envelope: the bivalent, quadrivalent and ninevalent HPV vaccines. Following administration of the vaccines, the immune system is being stimulated, producing antibodies to the HPV particles that protect against infection and disease. The safety profile of licensed HPV vaccines based on clinical and post-marketing data is reassuring
Files
Thanasas et al.pdf
Files
(139.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:2de19a8e664add15b78ea79e65406b38
|
139.1 kB | Preview Download |